Cargando…
Erratum to: Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study
Autores principales: | Ma, Jian-Da, Wei, Xiu-Ning, Zheng, Dong-Hui, Mo, Ying-Qian, Chen, Le-Feng, Zhang, Xiang, Li, Jin-Hua, Dai, Lie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634159/ https://www.ncbi.nlm.nih.gov/pubmed/26538264 http://dx.doi.org/10.1186/s13075-015-0837-5 |
Ejemplares similares
-
Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study
por: Ma, Jian-Da, et al.
Publicado: (2015) -
Erratum: Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013) -
Serum Matrix Metalloproteinase-3 as a Noninvasive Biomarker of Histological Synovitis for Diagnosis of Rheumatoid Arthritis
por: Ma, Jian-Da, et al.
Publicado: (2014) -
Erratum to: Self-reported flares are predictors of radiographic progression in rheumatoid arthritis patients in 28-joint disease activity score remission: a 24-month observational study
por: Ometto, Francesca, et al.
Publicado: (2016) -
Erratum to: Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study
por: Paalanen, Kirsi, et al.
Publicado: (2021)